Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 3 2015

Print

Search Results for 'Jubilant'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Search Results:

Published May 13, 2014
Aims to develop drug for unmet needs in pain management Read More »
By Kristin Brooks
Published February 19, 2014
Aims to advance programs in multiple disease areas Read More »
By Gil Roth
Published December 10, 2013
Spokane CMO facility cited by agency Read More »
Published November 14, 2013
Disruption not expected to impact Tesamorelin shipment Read More »
Published August 14, 2013
Expands Montreal ampoule manufacturing capacity Read More »
Published August 8, 2013
Prostate cancer drug to enter clinical trials later this year Read More »
Published August 8, 2013
Prostate cancer drug to enter clinical trials later this year Read More »
Published February 11, 2013
Will manufacture and supply DEFINITY, Cardiolite and Neurolite Read More »
Published November 14, 2012
Will manufacture sterile products at Spokane and Montreal sites Read More »
Published September 24, 2012
Will offer full suite of testing capabilities in Spokane, Montreal Read More »
Published September 6, 2012
Increases API supply for cardiac PET scanners Read More »
Published July 23, 2012
Pharmaceutical sales rose, but Contract Services were flat. Read More »
Published July 11, 2012
Installs PlantWeb digital plant architecture at three plants in India Read More »
Published May 7, 2012
Jubilant LifeSciences 4Q Revenues: $216.2 million 4Q Loss: $11.7 million FY Revenues: $786.7 million FY Earnings: $2.8 million Comments: CMO operations, including the Jubilant HollisterStier operations, were up 17% year-on-year to $114 million i… Read More »
Published April 13, 2012
Special Economic Zone includes global manufacturing facilities Read More »
By Gil Roth
Published February 22, 2012
Will manufacture sterile parenteral products at Spokane facility Read More »
Published February 21, 2012
Will identify preclinical candidates for neuropsychiatric diseases Read More »
Published February 9, 2012
Endo selects drug candidate for development Read More »
Published February 6, 2012
Revenue in the quarter up 25%, but earnings fall on INR-USD currency movement Read More »
By Gil Roth
Published October 19, 2011
How do you manage client expectations during an expansion? Read More »
Published October 18, 2011
Jubilant to deliver preclinical candidates for gastrointestinal therapeutics Read More »
Published September 14, 2011
Contract valued at more than $70 million Read More »
Published September 4, 2011
Montreal, Quebec, Canada, September 14, 2011- Jubilant HollisterStier Contract Manufacturing announced today that their Montreal-based facility has entered into a four year contract to manufacture a leading over the counter (OTC) prescription-strengt… Read More »
Published August 12, 2011
Contract valued at more than $80 million Read More »
By Gil Roth
Published August 9, 2011
CMO, Discovery/Development revenues rise Read More »
By Gil Roth
Published June 28, 2011
Three-year deal will focus on neuroscience candidates Read More »
Published June 23, 2011
Jubilant Biosys Ltd., a subsidiary of Jubilant Life Sciences Ltd., has successfully completed an early stage milestone in its neuroscience collaboration with AstraZeneca in the pain therapeutic area. Read More »
By Gil Roth
Published June 20, 2011
Development candidate to advance in oncology Read More »
Published June 1, 2011
David A. Linn has been named director of business intelligence and business development for Jubilant HollisterStier’s Contract Manufacturing & Services Division. Read More »
Published April 15, 2011
HollisterStier Contract Manufacturing, Spokane, Washington, USA, and Draxis Pharma General Partnership, Kirkland , Quebec, Canada, announced today that they have formally aligned the branding of their contract manufacturing & services under the n… Read More »
Published January 27, 2010
Jubilant Biosys Ltd., a subsidiary of Jubilant Organosys Ltd., and Endo Pharmaceuticals have expanded their drug discovery partnership in oncology, following the delivery of an early stage milestone. Read More »
Published January 11, 2010
Jubilant Biosys Ltd., a subsidiary of Jubilant Organosys Ltd. based in Bangalore India, has entered into a co-marketing agreement with Fremont, CA-based DiscoveRx Corp. to provide screening solutions. Read More »
Published November 24, 2009
Jubilant Organosys, the University of Alabama at Birmingham (UAB), and Southern Research Institute formed a joint venture leveraging their collective technologies in the areas of oncology, metabolic disease and infectious diseases. Read More »
Published June 11, 2009
Jubilant Biosys, a Bangalore-based subsidiary of Jubilant Organosys Ltd., has entered into a discovery and development collaboration with Endo Pharmaceuticals to develop a portfolio of oncology targets with a focus on delivering preclinical candidates for Read More »
Published May 5, 2009
Jubilant Biosys Ltd., a Bangalore-based subsidiary of Jubilant Organosys, has signed a research collaboration agreement with AstraZeneca focused on delivering preclinical drug candidates into AZ's pipeline. Read More »
Published October 30, 2008
Jubilant Organosys has strategically aligned its two entities, U.S.-based HollisterStier Laboratories and Canada-based Draxis Specialty Pharmaceuticals, and has assigned new leadership roles. The alignment is in an effort to leverage the strengths of… Read More »
Published April 7, 2008
Jubilant Organosys Ltd. and Draxis Health, Inc. have entered into an agreement whereby Jubilant will acquire all outstanding common shares of Draxis for approximately $255 million.     Mr. Shyam S. Bhartia, chairman and managing dir… Read More »
By Joanna Cosgrove
Published May 4, 2007
Jubilant News for Hollister-Stier By Joanna Cosgrove In what’s been billed as the largest overseas acquisition in contract manufacturing sector by an Indian company, Hollister-Stier Laboratories LLC, a Spokane, WA-based contract manuf… Read More »
Published April 25, 2007
In a surprise announcement during the first morning of INTERPHEX2007, Jubllant Organosys acquired Hollister-Stier Laboratories (HS), a Spokane, WA-based contract manufacturer of sterile Injectable vials and lyophilization products, for $122.5 million… Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On